?. Génétique and . ???????????, 25 1. Généralités sur l'hémoglobine ???????, p.25

?. .. Physiopathologie, . ????, . ???????, . ????, . ???????? et al., 30 a) Histoire naturelle de la maladie ?????????????, ????. 30 b) Complications aiguës ?????????..????????...???? 31 c) Complications chroniques ?????????..?????...????? 33

. .. Particularités-des-syndromes-hétérozygotes-composites?????? and . ????, 34 a) Les thalasso-drépanocytaires S ? 0 thalassémiques ????, ?????. 34 b) Les hétérozygotes composites SC et S ? + thalassémiques ??..???? 34 c) Le trait drépanocytaire ?????????????????...???? 34

G. Qu and ?. , en est-il des corticoïdes locaux ou inhalés?, p.76

L. Intensité-de and . Cvo, Nombre de sites de CVO Durée d'hospitalisation $ 8

E. Espace-interquartiles, #. Test, U. De-mann-whitney, and . Unité, Scores de Hebbel, administration et conséquences de la corticothérapie en fonction du sexe 2, Tableau, vol.15

L. Intensité-de and . Cvo, Nombre de sites de CVO Durée d'hospitalisation $ 7

C. Saint-martin, R. M. Bibrac, A. Brudey, K. Tarer, V. Divialle-doumdo et al., Universal newborn screening for haemoglobinopathies in Guadeloupe (French West Indies): A 27-year experience, Journal of Medical Screening, vol.14, issue.3, pp.177-82, 2013.
DOI : 10.1136/jcp.2008.058859

H. Bunn, Pathogenesis and Treatment of Sickle Cell Disease, N Engl J Med. 11 sept, vol.337, issue.11, pp.762-771, 1997.

F. Lionnet, K. Stankovic, and R. Girot, Drépanocytose de l'adulte. EMC -Hématologie, janv, vol.4, issue.2, pp.1-19, 2009.

H. Autorité-de-santé-ald, 10 -Syndromes drépanocytaires majeurs de l'adulte [Internet]. [cité 2 août 2016]. Disponible sur

A. Habibi, J. Arlet, K. Stankovic, J. Gellen-dautremer, J. Ribeil et al., Recommandations françaises de prise en charge de la drépanocytose de l'adulte : actualisation 2015. Rev Médecine Interne, pp.5-8, 2015.
DOI : 10.1016/s0248-8663(15)60002-9

D. Darbari, R. S. Fasano, C. Minniti, O. O. Castro, V. Gordeuk et al., Severe Vaso-Occlusive Episodes Associated with Use of Systemic Corticosteroids in Patients with Sickle Cell Disease, Journal of the National Medical Association, vol.100, issue.8, pp.948-51, 2008.
DOI : 10.1016/S0027-9684(15)31410-3

. Présentation-du-centre, Disponible sur: https://www.chuguadeloupe .fr/la-filiere-de-prise-en-charge/presentation-du-centre-de-reference, p.843, 2016.

S. Chakravorty and T. Williams, Sickle cell disease: a neglected chronic disease of increasing global health importance, Archives of Disease in Childhood, vol.59, issue.1, pp.48-53, 2015.
DOI : 10.1136/archdischild-2013-303773

D. Labie and J. Elion, Bases moléculaires et physiopathologiques des maladies de l'hémoglobine. EMC - Hématologie, déc, vol.2, issue.4, pp.220-259, 2005.
DOI : 10.1016/s1155-1984(05)40430-6

V. Perronne, M. Roberts-harewood, D. Bachir, F. Roudot-thoraval, J. Delord et al., Patterns of mortality in sickle cell disease in adults in France and England, The Hematology Journal, vol.3, issue.1, pp.56-60, 2002.
DOI : 10.1038/sj.thj.6200147

S. Ballas, K. Gupta, and P. Adams-graves, Sickle cell pain: a critical reappraisal, Blood, vol.120, issue.18, pp.3647-56, 2012.
DOI : 10.1182/blood-2012-04-383430

B. Yawn, G. Buchanan, and A. Afenyi-annan, Management of Sickle Cell Disease, JAMA, vol.312, issue.10, pp.1033-1081, 2014.
DOI : 10.1001/jama.2014.10517

J. Arlet, P. Bartolucci, A. Habibi, J. Ribeil, K. Stankovic et al., L???an??mie chez le patient dr??panocytaire adulte, La Revue de M??decine Interne, vol.30, pp.319-341, 2009.
DOI : 10.1016/j.revmed.2009.09.008

R. Hebbel, M. Boogaerts, J. Eaton, and M. Steinberg, Erythrocyte Adherence to Endothelium in Sickle-Cell Anemia, New England Journal of Medicine, vol.302, issue.18, pp.992-997, 1980.
DOI : 10.1056/NEJM198005013021803

K. Lee, P. Gane, F. Roudot-thoraval, B. Godeau, D. Bachir et al., The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia, Blood, vol.98, issue.4, pp.966-71, 2001.
DOI : 10.1182/blood.V98.4.966

R. Bone, R. Balk, F. Cerra, R. Dellinger, A. Fein et al., Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis, The ACCP/SCCM Consensus Conference Committee, pp.1644-55, 1992.
DOI : 10.1378/chest.101.6.1644

O. Platt, D. Brambilla, W. Rosse, P. Milner, O. Castro et al., Mortality In Sickle Cell Disease -- Life Expectancy and Risk Factors for Early Death, New England Journal of Medicine, vol.330, issue.23, pp.1639-1683, 1994.
DOI : 10.1056/NEJM199406093302303

D. Powars, A. Hiti, E. Ramicone, C. Johnson, and L. Chan, Outcome in hemoglobin SC disease: A four-decade observational study of clinical, hematologic, and genetic factors, American Journal of Hematology, vol.5, issue.10, pp.206-221, 2002.
DOI : 10.1002/ajh.10140

J. Strouse, M. Hulbert, M. Debaun, L. Jordan, and J. Casella, Primary Hemorrhagic Stroke in Children With Sickle Cell Disease Is Associated With Recent Transfusion and Use of Corticosteroids, PEDIATRICS, vol.118, issue.5, pp.1916-1940, 2006.
DOI : 10.1542/peds.2006-1241

J. Whitworth, M. Brown, J. Kelly, and P. Williamson, Mechanisms of cortisol-induced hypertension in humans, Steroids, vol.60, issue.1, pp.76-80, 1995.
DOI : 10.1016/0039-128X(94)00033-9

M. Shapiro and J. Hayes, Fat embolism in sickle cell disease. Report of a case with brief review of the literature, Archives of Internal Medicine, vol.144, issue.1, pp.181-183, 1984.
DOI : 10.1001/archinte.144.1.181

D. Gladman and C. Bombardier, Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis, Arthritis & Rheumatism, vol.9, issue.9, pp.1065-1073, 1987.
DOI : 10.1002/art.1780300916

J. Huang, R. Gay, and S. Khella, Sickling crisis, fat embolism, and coma after steroids, The Lancet, vol.344, issue.8927, pp.951-953, 1994.
DOI : 10.1016/S0140-6736(94)92300-0

K. Johnson, J. Stastny, and D. Rucknagel, Fat embolism syndrome associated with asthma and sickle cell-??+-thalassemia, American Journal of Hematology, vol.27, issue.4, pp.354-361, 1994.
DOI : 10.1002/ajh.2830460418

S. Couillard, M. Benkerrou, R. Girot, V. Brousse, A. Ferster et al., Steroid treatment in children with sickle-cell disease, Haematologica, vol.92, issue.3, pp.425-431, 2007.
DOI : 10.3324/haematol.10800

M. Michel, A. Habibi, B. Godeau, D. Bachir, A. Lahary et al., Characteristics and Outcome of Connective Tissue Diseases in Patients with Sickle-Cell Disease: Report of 30 Cases, Seminars in Arthritis and Rheumatism, vol.38, issue.3, pp.228-268, 2008.
DOI : 10.1016/j.semarthrit.2007.10.003

R. Hebbel, M. Visser, J. Goodman, H. Jacob, and G. Vercellotti, Potentiated adherence of sickle erythrocytes to endothelium infected by virus., Journal of Clinical Investigation, vol.80, issue.5, pp.1503-1509, 1987.
DOI : 10.1172/JCI113233

D. Horton, D. Ferriero, and W. Mentzer, Nontraumatic fat embolism syndrome in sickle cell anemia, Pediatric Neurology, vol.12, issue.1, pp.77-80, 1995.
DOI : 10.1016/0887-8994(94)00108-E

P. Simkin and D. Downey, Hypothesis: retrograde embolization of marrow fat may cause osteonecrosis, J Rheumatol. oct, vol.14, issue.5, pp.870-872, 1987.

J. Mishler and P. Emerson, Development of Neutrophilia by Serially Increasing Doses of Dexamethasone, British Journal of Haematology, vol.67, issue.2, pp.249-57, 1977.
DOI : 10.1046/j.1537-2995.1976.16276155113.x

C. Anyaegbu, I. Okpala, Y. Akren-'ova, and L. Salimonu, Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia (SCA), European Journal of Haematology, vol.233, issue.suppl, pp.267-275, 1998.
DOI : 10.1111/j.1600-0609.1998.tb01036.x

S. Charache, F. Barton, R. Moore, M. Terrin, M. Steinberg et al., Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive ???Switching??? Agent, Medicine, vol.75, issue.6, pp.300-326, 1996.
DOI : 10.1097/00005792-199611000-00002

A. Saleh, H. Hillen, and A. Duits, Levels of Endothelial, Neutrophil and Platelet-Specific Factors in Sickle Cell Anemia Patients during Hydroxyurea Therapy, Acta Haematologica, vol.102, issue.1, pp.31-38, 1999.
DOI : 10.1159/000040964

E. Vichinsky, L. Neumayr, A. Earles, R. Williams, E. Lennette et al., Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease, New England Journal of Medicine, vol.342, issue.25, pp.1855-65, 2000.
DOI : 10.1056/NEJM200006223422502

K. Ohene-frempong, S. Weiner, L. Sleeper, S. Miller, S. Embury et al., Cerebrovascular accidents in sickle cell disease: rates and risk factors, Blood. 1 janv, vol.91, issue.1, pp.288-94, 1998.

R. Arnold, J. Dyer, A. Gould, G. Hohberger, and P. Low, Sensitivity to Vasovagal Maneuvers in Normal Children and Adults, Mayo Clinic Proceedings, vol.66, issue.8, pp.797-804, 1991.
DOI : 10.1016/S0025-6196(12)61197-5

A. Turhan, L. Weiss, N. Mohandas, B. Coller, and P. Frenette, Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm, Proceedings of the National Academy of Sciences, vol.99, issue.5, pp.3047-51, 2002.
DOI : 10.1073/pnas.052522799

A. Blum, S. Yeganeh, A. Peleg, F. Vigder, K. Kryuger et al., Endothelial Function in Patients with Sickle Cell Anemia During and After Sickle Cell Crises, Journal of Thrombosis and Thrombolysis, vol.81, issue.1, pp.83-89, 2005.
DOI : 10.1007/s11239-005-1377-7

E. Fadlon, S. Vordermeier, T. Pearson, A. Mire-sluis, D. Dumonde et al., Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64, Blood. 1 janv, vol.91, issue.1, pp.266-74, 1998.

B. Adler, D. Salzman, M. Carabasi, W. Vaughan, V. Reddy et al., Fatal sickle cell crisis after granulocyte colony-stimulating factor administration, Blood, vol.97, issue.10, pp.3313-3317, 2001.
DOI : 10.1182/blood.V97.10.3313

Y. Wali, I. Beshlawi, N. Fawaz, A. Alkhayat, M. Zalabany et al., Coexistence of sickle cell disease and severe congenital neutropenia: first impressions can be deceiving, European Journal of Haematology, vol.11, issue.Suppl 3, pp.245-254, 2012.
DOI : 10.1111/j.1600-0609.2012.01827.x

T. Wun, The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease; Haemoglobinopathy, Hematol Amst Neth, vol.5, issue.5, pp.403-415, 2001.

S. Ballas, B. Files, L. Luchtman-jones, L. Benjamin, P. Swerdlow et al., Levels in Patients with Sickle Cell Disease and Acute Chest Syndrome, Hemoglobin, vol.16, issue.5, pp.165-70, 2006.
DOI : 10.1081/HEM-120035919

L. Styles, C. Schalkwijk, A. Aarsman, E. Vichinsky, B. Lubin et al., Phospholipase A2 levels in acute chest syndrome of sickle cell disease, Blood. 15 mars, vol.87, issue.6, pp.2573-2581, 1996.

R. Schleimer, Effects of glucocorticosteroids on inflammatory cells relevant to their therapeutic applications in asthma, Am Rev Respir Dis. févr, vol.141, issue.2 2, pp.59-69, 1990.

J. Bernini, Z. Rogers, E. Sandler, J. Reisch, C. Quinn et al., Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease, Blood. 1 nov, vol.92, issue.9, pp.3082-3091, 1998.

T. Griffin, D. Mcintire, and G. Buchanan, High-Dose Intravenous Methylprednisolone Therapy for Pain in Children and Adolescents with Sickle Cell Disease, New England Journal of Medicine, vol.330, issue.11, pp.733-740, 1994.
DOI : 10.1056/NEJM199403173301101

C. Quinn, M. Stuart, K. Kesler, K. Ataga, W. Wang et al., Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease, British Journal of Haematology, vol.272, issue.2, pp.263-270, 2011.
DOI : 10.1111/j.1365-2141.2011.08827.x

J. Belcher, H. Mahaseth, T. Welch, A. Vilback, K. Sonbol et al., Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice, AJP: Heart and Circulatory Physiology, vol.288, issue.6, pp.2715-2725, 2005.
DOI : 10.1152/ajpheart.00986.2004

R. Liem, O. Gorman, M. Brown, and D. , Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome, American Journal of Hematology, vol.5, issue.1, pp.19-25, 2004.
DOI : 10.1002/ajh.20054

M. Isakoff, J. Lillo, and J. Hagstrom, A Single-Institution Experience With Treatment of Severe Acute Chest Syndrome: Lack of Rebound Pain With Dexamethasone Plus Transfusion Therapy, Journal of Pediatric Hematology/Oncology, vol.30, issue.4, pp.322-327, 2008.
DOI : 10.1097/MPH.0b013e3181647bb2

J. Strouse, C. Takemoto, J. Keefer, G. Kato, and J. Casella, Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease, Pediatric Blood & Cancer, vol.91, issue.5, pp.1006-1018, 2008.
DOI : 10.1002/pbc.21336

J. Boyd, E. Macklin, R. Strunk, and M. Debaun, Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia, Blood, vol.108, issue.9, pp.2923-2930, 2006.
DOI : 10.1182/blood-2006-01-011072

J. Boyd, E. Macklin, R. Strunk, and M. Debaun, Asthma is associated with Increased mortality in individuals with sickle cell anemia, Haematologica, vol.92, issue.8, pp.1115-1123, 2007.
DOI : 10.3324/haematol.11213

J. Boyd, A. Moinuddin, R. Strunk, and M. Debaun, Asthma and acute chest in sickle-cell disease, Pediatric Pulmonology, vol.121, issue.3, pp.229-261, 2004.
DOI : 10.1002/ppul.20066

J. Glassberg, R. Strunk, and M. Debaun, Wheezing in children with sickle cell disease, Current Opinion in Pediatrics, vol.26, issue.1, pp.9-18, 2014.
DOI : 10.1097/MOP.0000000000000045